Inari Medical (NASDAQ:NARI) Earns Hold Rating from Analysts at Stifel Nicolaus
Stifel Nicolaus initiated coverage on shares of Inari Medical (NASDAQ:NARI – Free Report) in a research report released on Tuesday morning, Marketbeat.com reports. The firm issued a hold rating and a $50.00 price target on the stock. Several other equities analysts have also recently commented on NARI. Piper Sandler reiterated a neutral rating and set […]
More Stories
Coast Guard Offloads $28 Million Worth of Seized Cocaine in Miami Beach
By Naveen Athrappully The crew of U.S. Coast Guard Cutter Tampa offloaded roughly 3,825 pounds of cocaine valued at over...
NY Loses Nearly $74 Million for Not Revoking Commercial Driver’s Licenses Unlawfully Issued to Foreigners
By Jill McLaughlin The U.S. Department of Transportation will withhold $73.5 million in federal funding from New York for failing...
2nd Round of Iran Peace Talks Could Come This Weekend, Trump Says
By Ryan Morgan A second round of peace talks between the United States and Iran could take place this weekend,...
Historically Low Jobless Claims Signal Stable US Labor Market
By Andrew Moran The number of Americans filing for unemployment benefits remained around historically low levels, signaling a stable U.S....
Alzheimer’s Drugs Have No ‘Meaningful Effect’ on Cognitive Decline: Review
By Zachary Stieber A class of Alzheimer’s drugs that have only been available for several years did not appear to...
Hegseth Says US ‘Locked and Loaded’ to Strike Iran’s Power Plants If No Deal Reached
By Jack Phillips U.S. Secretary of War Pete Hegseth on April 16 urged Iran’s leadership to reach a deal with...